Skip to content
Screener

D&A at other companies

Abbott logo
AbbottABT
$658M+56.7%
Natera, Inc. logo
Natera, Inc.NTRA
$5.7M
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$419K0.0%
Lumexa Imaging Holdings, Inc. logo
Lumexa Imaging Holdings, Inc.LMRI
$9.92M+9.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$2.03M+2.1%
Lucid Diagnostics logo
Lucid DiagnosticsLUCD
$105K0.0%

Segments

By segment

See full
Reportable Segment$36.96M-0.8%

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%
P/S16.5×+7.6×

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Return on equity-16.1%-1.3pp
Debt / equity0.0×
Current ratio10.9×+1.7×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307
Line itemThree Months Ended / June 30,2026Three Months Ended / June 30,2025Six Months Ended / June 30,2026Six Months Ended / June 30,2025
Costs and operating expenses:
Cost of screening revenue (exclusive of amortization of intangible assets)23,34719,34644,59136,469
Cost of development services revenue4345018101,672
Cost of revenue — amortization of intangible assets33,47233,47266,94466,944
Research and development47,42946,62695,450100,251
Sales and marketing37,65728,53968,32563,518
General and administrative50,70837,91493,47782,988
Intangible and other assets impairment25,42328,00025,42328,000

Item 1. Financial Statements

FAQ

What is GRAIL, Inc.'s D&A?
GRAIL, Inc. (GRAL) reported D&A of $33.47M in Q2 2026.
How has GRAIL, Inc.'s D&A changed year-over-year?
GRAIL, Inc.'s D&A decreased by 0.0% year-over-year, from $33.47M to $33.47M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Ask your AI about GRAIL, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude